These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 15798388)

  • 1. Sea snails help neuropathic pain.
    AIDS Patient Care STDS; 2005 Mar; 19(3):204-5. PubMed ID: 15798388
    [No Abstract]   [Full Text] [Related]  

  • 2. Spinal actions of ω-conotoxins, CVID, MVIIA and related peptides in a rat neuropathic pain model.
    Jayamanne A; Jeong HJ; Schroeder CI; Lewis RJ; Christie MJ; Vaughan CW
    Br J Pharmacol; 2013 Sep; 170(2):245-54. PubMed ID: 23713957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful reduction of neuropathic pain associated with spinal cord injury via of a combination of intrathecal hydromorphone and ziconotide: a case report.
    Saulino M
    Spinal Cord; 2007 Nov; 45(11):749-52. PubMed ID: 17310258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ziconotide: new drug. Limited analgesic efficacy, too many adverse effects.
    Prescrire Int; 2008 Oct; 17(97):179-82. PubMed ID: 19530373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ziconitide.
    Greenberg EN
    J Pain Palliat Care Pharmacother; 2011; 25(4):380-1. PubMed ID: 22126177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recommendations for the management of chronic pain by intrathecal ziconotide].
    Tronnier V; Hofacker W; Ilias W; Kleinmann B; Koulousakis A; Kress HG; Likar R; Lux EA; Müller-Schwefe G; Schütze G; Uberall M
    MMW Fortschr Med; 2010 Oct; 152 Suppl 3():106-9. PubMed ID: 21595155
    [No Abstract]   [Full Text] [Related]  

  • 7. Ziconotide Trialing by Intrathecal Bolus Injections: An Open-Label Non-Randomized Clinical Trial in Postoperative/Posttraumatic Neuropathic Pain Patients Refractory to Conventional Treatment.
    Bäckryd E; Sörensen J; Gerdle B
    Neuromodulation; 2015 Jul; 18(5):404-13. PubMed ID: 25879804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using ziconotide for intrathecal infusions.
    Mitchell AA; Sapienza-Crawford AJ; Hanley KL; Lokey KJ; Wells L
    Nursing; 2008 Dec; 38(12):19. PubMed ID: 19033968
    [No Abstract]   [Full Text] [Related]  

  • 9. Trigeminal neuralgia relief with intrathecal ziconotide.
    Michiels WB; McGlthlen GL; Platt BJ; Grigsby EJ
    Clin J Pain; 2011 May; 27(4):352-4. PubMed ID: 21494183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ziconotide infusion for severe chronic pain: case series of patients with neuropathic pain.
    Wermeling DP; Berger JR
    Pharmacotherapy; 2006 Mar; 26(3):395-402. PubMed ID: 16503720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of First-Line Ziconotide Intrathecal Drug Therapy for Neuropathic Pain on Disability, Emotional Well-Being, and Pain Catastrophizing.
    Shao MM; Khazen O; Hellman A; Czerwinski M; Dentinger R; DiMarzio M; Gillogly M; Hadanny A; Argoff C; Pilitsis JG
    World Neurosurg; 2021 Jan; 145():e340-e347. PubMed ID: 33096281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ziconotide.
    Strigenz T
    J Pain Palliat Care Pharmacother; 2014 Mar; 28(1):73-4. PubMed ID: 24397285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential Uses of Isolated Toxin Peptides in Neuropathic Pain Relief: A Literature Review.
    Hamad MK; He K; Abdulrazeq HF; Mustafa AM; Luceri R; Kamal N; Ali M; Nakhla J; Herzallah MM; Mammis A
    World Neurosurg; 2018 May; 113():333-347.e5. PubMed ID: 29421449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neuropsychiatric side effects of intrathecal ziconotide].
    Ayuga-Loro F; Brocalero-Camacho Á; Quintas-López MV; Cabrera-Feria JR
    Rev Neurol; 2011 Jan; 52(1):61-3. PubMed ID: 21246497
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experience in treatment of patients with neuropathic facial pain using ziconotide].
    Lux EA; Rasche D
    Schmerz; 2011 Aug; 25(4):434-9. PubMed ID: 21818721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omega-conotoxins as experimental tools and therapeutics in pain management.
    Hannon HE; Atchison WD
    Mar Drugs; 2013 Mar; 11(3):680-99. PubMed ID: 23470283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An effective treatment of severe complex regional pain syndrome type 1 in a child using high doses of intrathecal ziconotide.
    Stanton-Hicks M; Kapural L
    J Pain Symptom Manage; 2006 Dec; 32(6):509-11. PubMed ID: 17157748
    [No Abstract]   [Full Text] [Related]  

  • 18. Statistical evaluation of the chemical stability of ziconotide solutions during simulated intrathecal administration.
    Shields DE; Liu W; Gunning K; Montenegro R
    J Pain Symptom Manage; 2008 Jul; 36(1):e4-6. PubMed ID: 18538975
    [No Abstract]   [Full Text] [Related]  

  • 19. [Ziconotide: an innovative alternative for intense chronic neuropathic pain].
    Valía-Vera JC; Villanueva VL; Asensio-Samper JM; López-Alarcón MD; de Andrés JA
    Rev Neurol; 2007 Dec 1-15; 45(11):665-9. PubMed ID: 18050098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new approach to chronic pain.
    Barker E
    RN; 2005 May; 68(5):32ac1-32ac4; quiz 32ac5. PubMed ID: 15931928
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.